25 May 2013
Keywords: serono, files, raptiva, europe, switzerland, filed, approval
Article | 03 March 2003
Serono of Switzerland has filed for approval to market its psoriasistreatment Raptiva (efalizumab) in the European Union, just days after ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.